Progression-free survival in a retrospective melanoma immunotherapy cohort by baseline Ruminococcaceae status
No takes yet. Share an insight, caveat, or question.
Glitza et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: